All News
Year in Review #ACR22
Pre-expos PPx for COVID!
Tix-Cil (Evusheld): risk reduction 77%
Cardiac AES 0.6% vs placebo 0.2%
Only 3.3% were on immunosuppression
But Israeli study with immunosuppressed:
92% half as likely to be hospitalized or die
1/2 less infections
@RheumNow
Eric Dein ericdeinmd ( View Tweet)
Ab1291 #ACR22: 🔥Ignite🔥
@DavidLeverenz: Constructed a model to identify telehealth visits - PPV 0.8, sensitivity 0.39 - better than existing practice (PPV 0.77)
Predictors: age, diagnoses, medications, RAPID3, provider preference for 💻🩺
3 mo pilot program predictive
@RheumNow https://t.co/Iey87SVGv4
Eric Dein ericdeinmd ( View Tweet)
Very important point about statin induced myopathy by Dr. Christopher-Stine.
If 1) history of statin exposure, 2) typical symptoms of myositis 3) HMGCR ab positive — do NOT need biopsy and can treat as statin associated necrotizing autoimmune myopathy!
@RheumNow #ACR22 https://t.co/VHxPRkCWwj
Robert B Chao, MD doctorRBC ( View Tweet)
Among ANCA-vasculitis hospitalizations, A Fib found to be most common CV condition. Females had fewer CV complications, lower in-hospital mortality & shorter length of stay compared to males. Abs 0434 #ACR22 https://t.co/2IikApUdvE https://t.co/16ggVScs3a
Dr. Rachel Tate uptoTate ( View Tweet)
SELECT-AXIS 2 subgroup analysis. UPA demonstrated improved efficacy vs PBO at Wk 14 across all evaluated subgroups of pts with bDMARD-IR AS. No new safety signals. @XBaraliakos et al, Abs 0414 #ACR22 https://t.co/lTfm68XlEY https://t.co/PaWdrOljMO
Dr. Rachel Tate uptoTate ( View Tweet)
Do you check ANCAs in your ILD pts? Abs 0438 at #ACR22 suggests you should! @RheumNow
https://t.co/W8rRAdWFQh https://t.co/RQfcQQUVzI
Dr. Rachel Tate uptoTate ( View Tweet)
Headed to the #ACR22 Fellows in Training (FIT) session for a round table on keeping up with the medical literature!
As usual, updated handout for this year 🤓
@MithuRheum Wish I had thought to ask you for help w/my graphics-game! Not my strength hahaha
#ACRAmbassador https://t.co/Tg4ZT262rU
Mike Putman EBRheum ( View Tweet)
Very cool initiative @Robsonjo4
1. I love patient reported outcomes (PROs)
2. I think we under-appreciate how much steroids affect our patients quality of life
Looking forward to seeing this live!
#ACR22 #Vasculitis22 @RheumNow https://t.co/1akO1k7VgU
Mike Putman EBRheum ( View Tweet)
Interesting study about causes of death in GCA
I never know what to make of these; our pts typically die of the usual things (cancer, CVD) and have increased risks of infection (due to treatment)
Is there USA data about this?
#ACRAmbassador #ACR22 https://t.co/ZMOSD7lYGL
Mike Putman EBRheum ( View Tweet)
Regional Winners (people's choice award goes to North America tumoral calcinosis) #ACR22 Image Competition @rheumnow https://t.co/y7dDHc75PQ
TheDaoIndex KDAO2011 ( View Tweet)
“I don’t live in an igloo, I don’t have a dog sled, and yes we do have daylight some times of the year – Dr. John Botson (from Alaska) answering questions on everyone's mind before he presented the MIRROR RCT study #Plenary1 #ACR22 @rheumnow https://t.co/y23Keeh3r8
TheDaoIndex KDAO2011 ( View Tweet)
What has changed since the 2020 @ACRheum #reproductive guidelines?
Abstract #1717 425 SLE/RA patients:
📍 significant improvement in pre-#pregnancy counseling and discussions in reproductive goals
📍No improvements in birth control use or documentation
Catherine Sims, MD DrCassySims ( View Tweet)
#RheumPearls: Check APLs in all SLE pts because they influences contraceptive choice, postpartum/surgery anticoag prophylx, and HRT counseling
Dr. J Kolfenbach #ACR22 @rheumnow https://t.co/Hnrh4NhmBj
TheDaoIndex KDAO2011 ( View Tweet)
We share our vision of what rheumatologists should be considering thinking and doing regarding COVID-19 in our immunocompromise patients. Would love your reactions @CCalabreseDO @BetsyKirch @DrPujaMehta1 @alhkim @drdavidliew @philipcrobinson #ACR22 https://t.co/OpmoEOXWmL
Leonard Calabrese LCalabreseDO ( View Tweet)
This year, as every year, at ACR (and EULAR) I am amazed by some of what are oral presentations vs what is in the posters. Please check out the poster sessions, there are some absolute gems in there! I will amplify the ones I find that I feel competent to discuss #ACR22
Richard Conway RichardPAConway ( View Tweet)
Primary care provider education can improve rheumatology care:
➤ Post-training ratings in confidence and knowledge improved compared to baseline
➤ Gives me confidence for my own local programme RheumACaN for GPs,PCPs
Mandal J 0005 https://t.co/MCb7QTcYsL #ACR22 @RheumNow https://t.co/sTYFtbbvtT
Dr. Antoni Chan synovialjoints ( View Tweet)
HCQ tx thresholds study by Prof Garg:
🔸HCQ >=500ng/ml: good threshold to detect adherence
🔸HCQ 750-1000ng/ml: effective thresholds to prevent flares
🔸CKD>=2: 4x ⬆️odds of HCQ>1500ng/ml (supraTx! dose adj.)
Interesting data.
Game changing?🧐
#ACR22 @RheumNow ABST#0344 #ACRBest https://t.co/GxlucrTeE5
sheila RHEUMarampa ( View Tweet)
Interesting data on TNFi use in ankylosing spondylitis.
Early TNFi use, compared to no TNFi associated with higher CVD, stroke and MACE.
@rheum_cat any thought on why? and why there were so many non-TNFi users (15k vs. 2k)?
Abs#0415 @RheumNow #ACR22 https://t.co/PVkt8gPHFW
Robert B Chao, MD doctorRBC ( View Tweet)
ACEi improve survival in SSc Renal Crisis
◦ Routine use of ACEi as prophylaxis is a myth
◦ ACEi prophylaxis may set up a chronic, less reversible process
◦ Best used in high BP, low creatinine - bring on the ACEi then
John Stone, Secrets and Pearls #ACR22 @RheumNow https://t.co/3leCEmtaj1
Dr. Antoni Chan synovialjoints ( View Tweet)
Add GPA to the list of causes of dacryoadenitis (inflammation of the lacrimal gland, main or accessory). Differential diagnoses of dacryoadenitis:
● Sjogren's
● Sarcoidosis
● IgG4 RD
● AL Amyloidosis
● GPA
John Stone, Secrets and Pearls #ACR22 @RheumNow https://t.co/dvXbkpfcAq
Dr. Antoni Chan synovialjoints ( View Tweet)